Mod GRF 1-29: Comprehensive Research Guide

Overview

Mod GRF 1-29 (Modified Growth Hormone-Releasing Hormone 1-29) is a synthetic analog of GHRH with modifications to enhance stability and half-life. It stimulates the pituitary gland to produce and release growth hormone in a natural, pulsatile pattern.

Mechanism of Action

Growth Hormone Release

• Pituitary Stimulation: Activates GHRH receptors
• Natural Pattern: Promotes pulsatile GH release
• Stability: Enhanced stability compared to natural GHRH
• Selective: More selective than direct GH administration

Advantages

• Natural Pattern: Maintains natural GH pulsatility
• Feedback: Preserves negative feedback loops
• Safety: Lower risk than direct GH
• Stability: More stable than natural GHRH

Research Applications

Growth Hormone Research

• GH Deficiency: Research into GH deficiency
• Aging: Research into age-related GH decline
• Recovery: Enhanced recovery research
• Body Composition: Research into body composition changes

Dosage

• Research: 100-300 mcg daily
• Typical: 200 mcg before bedtime
• Administration: Subcutaneous injection
• Timing: Best before sleep

Side Effects

• Minimal: Generally well-tolerated
• Injection Site: Mild irritation possible
• No Hormonal: Does not affect other hormones

Storage

• Temperature: 2-8°C (refrigerated)
• Light: Protect from light
• Reconstituted: Stable for 2-3 weeks

This information is for research and educational purposes only.